DOI QR코드

DOI QR Code

Newly Developed Weakness of Lower Extremities Despite Improved Brain Metastasis of Lung Cancer after Radiotherapy

  • Yang, Jae Hyun (Department of Internal Medicine, Korea Cancer Center Hospital) ;
  • Jang, Young Joo (Department of Internal Medicine, Korea Cancer Center Hospital) ;
  • Ahn, Se Jin (Department of Internal Medicine, Korea Cancer Center Hospital) ;
  • Kim, Hye-Ryoun (Department of Internal Medicine, Korea Cancer Center Hospital) ;
  • Kim, Cheol Hyeon (Department of Internal Medicine, Korea Cancer Center Hospital) ;
  • Koh, Jae Soo (Department of Pathology, Korea Cancer Center Hospital) ;
  • Choe, Du Hwan (Department of Radiology, Korea Cancer Center Hospital) ;
  • Lee, Jae Cheol (Department of Internal Medicine, Korea Cancer Center Hospital)
  • 투고 : 2009.09.04
  • 심사 : 2009.10.05
  • 발행 : 2009.12.30

초록

An intramedullary spinal cord metastasis (ISCM) rarely develops in systemic cancer but is indicative of a poor prognosis. A 56-year-old man was admitted due to weakness of the lower extremities. He had received radiotherapy 3 months prior for a brain metastasis that had developed 1 year after achieving a complete response from chemotherapy for extended stage small cell lung cancer. Although the brain lesion had improved partially, ISCM from the cervical to lumbar-sacral spinal cords, which was accompanied by a leptomeningeal dissemination, was diagnosed based on magnetic resonance imaging of the spine and cerebrospinal fluid cytology. Finally, he died of sudden cardiac arrest during treatment. This is the first case of ISCM involving the whole spinal segments. Physicians should be aware of the subsequent development of ISCM in lung cancer patients with a previously known brain metastasis who present with new neurological symptoms.

키워드

참고문헌

  1. Chason JL, Walker FB, Landers JW. Metastatic carcinoma in the central nervous system and dorsal root ganglia: a prospective autopsy study. Cancer 1963;16:781-7 https://doi.org/10.1002/1097-0142(196306)16:6<781::AID-CNCR2820160614>3.0.CO;2-M
  2. Moffie D, Stefanko SZ. Intramedullary metastasis. Clin Neurol Neurosurg 1980;82:199-202 https://doi.org/10.1016/0303-8467(80)90037-2
  3. Grem JL, Burgess J, Trump DL. Clinical features and natural history of intramedullary spinal cord metastasis. Cancer 1985;56:2305-14 https://doi.org/10.1002/1097-0142(19851101)56:9<2305::AID-CNCR2820560928>3.0.CO;2-X
  4. Okamoto H, Shinkai T, Matsuno Y, Saijo N. Intradural parenchymal involvement in the spinal subarachnoid space associated with primary lung cancer. Cancer 1993;72:2583-8 https://doi.org/10.1002/1097-0142(19931101)72:9<2583::AID-CNCR2820720912>3.0.CO;2-K
  5. Potti A, Abdel-Raheem M, Levitt R, Schell DA, Mehdi SA. Intramedullary spinal cord metastases (ISCM) and non-small cell lung carcinoma (NSCLC): clinical patterns, diagnosis and therapeutic considerations. Lung Cancer 2001;31:319-23 https://doi.org/10.1016/S0169-5002(00)00177-X
  6. Costigan DA, Winkelman MD. Intramedullary spinal cord metastasis: a clinicopathological study of 13 cases. J Neurosurg 1985;62:227-33 https://doi.org/10.3171/jns.1985.62.2.0227
  7. Kalayci M, Cağavi F, Gül S, Yenidünya S, Açikgöz B. Intramedullary spinal cord metastases: diagnosis and treatment - an illustrated review. Acta Neurochir (Wien) 2004;146:1347-54; discussion 1354 https://doi.org/10.1007/s00701-004-0386-1
  8. Grem JL, Burgess J, Trump DL. Clinical features and natural history of intramedullary spinal cord metastasis. Cancer 1985;56:2305-14 https://doi.org/10.1002/1097-0142(19851101)56:9<2305::AID-CNCR2820560928>3.0.CO;2-X
  9. Weissman DE, Grossman SA. Simultaneous leptomeningeal and intramedullary spinal metastases in small cell lung carcinoma. Med Pediatr Oncol 1986;14:54-6 https://doi.org/10.1002/mpo.2950140113
  10. Wasserstrom WR, Glass JP, Posner JB. Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer 1982;49:759- 72 https://doi.org/10.1002/1097-0142(19820215)49:4<759::AID-CNCR2820490427>3.0.CO;2-7